Cytecare collaborates with Brains to offer Radio Surgery treatment at Neuro-Oncology Centre in Bengaluru
Bengaluru, 25th July 2018: Cytecare Cancer Hospital and Brains Neuro Spine Centre launched a world-class Neuro-Onco Centre at Cytecare Cancer Hospital, Bengaluru. Under the guidance of Dr. Venkataramana, Stereotactic Radio Surgery (SRS) will be provided at the centre.
SRS is a form of radiation treatment. A ray is focused on the centre of the tumour without affecting the other parts of the brain. This involves a stereotactic principle to calculate the size and volume of the tumour, to outline the configuration of the tumour, and helps identify the vital or radiation sensitive structures surrounding the tumour.
Dr. Venkataramana, Senior Consultant Neuro Oncology, Cytecare and Founder & Chief Neurosurgeon, BRAINS said, “Radiation oncology has undergone immense changes over the years. With the development of technology in Radio Surgery, we are able to treat the tumour without affecting the other normal tissues and blood vessels of the brain”.
The procedure is used to treat tumours that are less than 3cm in size. Multiple tumours can be treated in different locations of the brain. The procedure is quick, and the radiation dose can be calculated, as per data received from MRI scans, and delivered within minutes.
Suresh Ramu, CEO Cytecare Cancer Hospitals, said, “Our focus is towards fighting the disease the right way and improving patient’s quality of life. We are zealous to offer this advanced radiation oncology treatment or Radio Surgery at our hospital, which helps our patients lead a better life”.
When tumours are located in critical areas, Stereotactic Fractionated Radiotherapy is performed, where the dose can be fragmented into portions, and given over 5-7 days. In addition to tumours, arteriovenous malformations can be treated using SRS.
Post treatment follow-up is essential to monitor the response and regression. The growth of the tumour will stop immediately and gradually regress in three years depending upon its size. Hence, it is important to repeat MRI scans every six months.
This process is safe for paediatric oncology as well as for the elderly. It is prescriptible for children above five years, for elderly people with co-morbidities who are not fit for open surgery, as well as patients with recurrent tumours after their primary surgery.
Disclaimer: Welthi.com does not guarantee any specific results as a result of the procedures mentioned here, and the results may vary from person to person.
